We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hologic and Cytyc To Focus on Advanced Technology in Women's Health

By MedImaging staff writers
Posted on 08 Nov 2007
Hologic, Inc. (Bedford, MA, USA) and Cytyc Corp. (Marlborough, MA, USA) announced the completion of the combination of the two companies, creating one of the largest companies in the world focused on advanced technology in women's health.

"We are delighted to have completed this transaction, which marks a new chapter in the history of our company,” said Jack Cumming, Hologic's chief executive officer. "Both Hologic and Cytyc provide some of the most advanced technology addressing women's health needs. By combining our companies' complementary, best-in-class products and technologies, we expect to drive enhanced growth and value creation. We are now focused on seamlessly integrating these two great companies and realizing the tremendous upside potential our combination creates.”

"We look forward to joining our talented teams and working together to reach our shared goal of improving women's health,” said Patrick Sullivan, chairman of Hologic and former chairman, president, and chief executive officer of Cytyc. "We are very excited to realize the extraordinary benefits this combination of industry leaders will provide to shareholders, employees, physicians, and their patients.”

Hologic is a developer, manufacturer, and supplier of premium diagnostic and medical imaging systems for the healthcare needs of women, and a developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C-arm and extremity magnetic resonance imaging (MRI) imaging for orthopedic applications.

Cytyc's products cover a range of cancer and women's health applications, including cervical cancer screening, preterm birth screening, treatment of excessive menstrual bleeding, and radiation treatment of patients with early-stage breast cancer.


Related Links:
Hologic
Cytyc
High-Precision QA Tool
DEXA Phantom
X-Ray Generator
Advantage Plus Generators
Ultrasound Needle Guidance System
SonoSite L25
X-Ray Illuminator
X-Ray Viewbox Illuminators

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.